Your browser doesn't support javascript.
Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19.
Dastan, Farzaneh; Saffaei, Ali; Mortazavi, Seyed Mehdi; Jamaati, Hamidreza; Adnani, Nadia; Samiee Roudi, Sasan; Kiani, Arda; Abedini, Atefeh; Hashemian, Seyed MohammadReza.
  • Dastan F; Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Ira
  • Saffaei A; Student Research Committee, Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Mortazavi SM; Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Jamaati H; Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Adnani N; Nephrology Research Center, Department of Nephrology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.
  • Samiee Roudi S; Infectious Research Center, Department of Infectious Disease, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Kiani A; Tracheal Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Abedini A; Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Hashemian SM; Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: iran.criticalcare@yahoo.com.
J Glob Antimicrob Resist ; 21: 340-341, 2020 06.
Article in English | MEDLINE | ID: covidwho-125519
ABSTRACT
Cytokine release syndrome is prevalent in severe cases of COVID-19. In this syndrome, an uncontrolled response of immune system occurs. Extracorporeal blood purification has been proven to effectively remove the released inflammatory cytokines. Here, we reported a successful case to represent our experience of extracorporeal blood purification in a patient with severe COVID-19.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Hemoperfusion / Renal Replacement Therapy / Coronavirus Infections Type of study: Case report Limits: Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: J Glob Antimicrob Resist Year: 2020 Document Type: Article Affiliation country: J.jgar.2020.04.024

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Hemoperfusion / Renal Replacement Therapy / Coronavirus Infections Type of study: Case report Limits: Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: J Glob Antimicrob Resist Year: 2020 Document Type: Article Affiliation country: J.jgar.2020.04.024